gap 1,066 words KG: GRN 2026-03-29
kind:gap-analysissection:gapsstate:published
Contents

GRN Carrier Resilience in Frontotemporal Dementia

Knowledge Graph

Related Analyses (6)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
How do pathological stress granules in neurodegeneration esc
neurodegeneration · failed
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · failed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (8)

Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40
FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

GRN therapeutic_target FUS
GRN therapeutic_target SOD1
GRN therapeutic_target C9ORF72
GRN encodes progranulin
GRN associated_with frontotemporal lobar degeneration
GRN inhibits aberrant microglia activation
GRN activates CTSB
GRN associated_with GAIN
GRN associated_with MAPT
GRN activates SPP1